Virtual PREHAB Study for Patients Undergoing TAVI
Launched by NOVA SCOTIA HEALTH AUTHORITY · Nov 14, 2022
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
The Virtual PREHAB Study is exploring a new way to help patients in Nova Scotia who need a special heart procedure called transcatheter aortic valve implantation (TAVI). Many older patients are frail and may struggle to recover after surgery, and some may even wait a long time for their procedure, which can make their health worse. The study aims to see if a virtual rehabilitation program, where patients can participate from home, can help improve their health and strength before they have TAVI. This program will be guided by a team of healthcare providers, including doctors and therapists.
To be eligible for this trial, patients must be attending the TAVI clinic at the Queen Elizabeth II Health Sciences Centre and be able to give consent. Individuals with severe heart failure, significant physical limitations, or those who cannot access the internet or a phone for virtual sessions will not be included. Participants can expect to receive support and guidance to improve their health, making their surgery experience better and helping them recover more effectively afterward. This study is important because it aims to make healthcare more accessible and improve outcomes for patients facing serious health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Outpatients attending the TAVI clinic at the Queen Elizabeth II Health Sciences Centre
- • Informed written or verbal consent
- Exclusion Criteria:
- • New York Heart Association or Canadian Cardiovascular Score of 4
- • Severe functional limitations
- • Cognitive impairment that impacts consenting ability
- • Significant language barrier
- • No internet or telephone access that precludes virtual PREHAB participation
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials